The supplementary medical market is a multi-billion dollar industry, and much of this is squarely aimed at a condition 50% of us can expect to contract beyond the age of 50 – osteoarthritis. So, what can we do about this for our patients? Should we be recommending supplements? Do they work? Do we even know what…
Simon Bartold
Director of Bartold Clinical
Leave a Reply
You must be logged in to post a comment.